Xuanni Tan

P.R. China
Chongqing, 400038, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Novel therapeutic strategies for targeting fatty acid oxidation in cancer.

Novel therapeutic strategies for targeting fatty acid oxidation in cancer.

Journal: Biomarker research
Published: May 29, 2025

Comparative study of surgical outcomes and quality of life between endoscopic and robotic thyroidectomy for differentiated thyroid cancer patients.

Comparative study of surgical outcomes and quality of life between endoscopic and robotic thyroidectomy for differentiated thyroid cancer patients.

Journal: International journal of surgery (London, England)
Published: March 18, 2025

CD36 Inhibits Triple-Negative Breast Cancer Progression by Transcriptionally Upregulating Caveolin-1 and Promoting Lipid-Reactive Oxygen Species-Related Ferroptosis.

CD36 Inhibits Triple-Negative Breast Cancer Progression by Transcriptionally Upregulating Caveolin-1 and Promoting Lipid-Reactive Oxygen Species-Related Ferroptosis.

Journal: MedComm
Published: November 14, 2024

Tumor-Derived Extracellular Vesicles Enable Tumor Tropism Chemo-Genetherapy for Local Immune Activation in Triple-Negative Breast Cancer.

Tumor-Derived Extracellular Vesicles Enable Tumor Tropism Chemo-Genetherapy for Local Immune Activation in Triple-Negative Breast Cancer.

Journal: ACS nano
Published: October 30, 2024

Landscape of metabolic alterations and treatment strategies in breast cancer.

Landscape of metabolic alterations and treatment strategies in breast cancer.

Journal: Genes & diseases
Published: March 13, 2024

Effectiveness of ultrasound-guided vacuum-assisted excision for treating benign breast lesions.

Effectiveness of ultrasound-guided vacuum-assisted excision for treating benign breast lesions.

Journal: Cancer innovation
Published: November 21, 2023

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

A multicenter single-arm trial of neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.

Journal: MedComm
Published: April 10, 2023

Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis.

Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis.

Journal: Therapeutic advances in medical oncology
Published: July 23, 2022

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review.

Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative Review.

Journal: Frontiers in pharmacology
Published: September 04, 2021

Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical Trial.

Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical Trial.

Journal: The oncologist
Published: September 07, 2020

Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.

Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.

Journal: Gland surgery
Published: May 19, 2020

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.

Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.

Journal: International journal of cancer
Published: November 08, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026